Alzheimer's drug begins human trials

Jun 27, 2007

Human clinical trials are under way for a U.S. drug to treat Alzheimer's disease, based on the design of a Purdue University researcher.

"Current drugs manage the symptoms, but this could be the first disease-modifying therapy," said Professor Arun Ghosh. "It may be able to prevent and reverse the disease."

Ghosh and Jordan Tang of the Oklahoma Medical Research Foundation developed the drug CTS-21166.

In 2000, Tang identified beta-secretase, a key enzyme in the progression of Alzheimer's that triggers the formation of amyloid plaques in the brain. Ghosh later built a molecule that binds to the enzyme and inhibits its activity.

"These molecules fit together like puzzle pieces," Ghosh said. "We created a molecule that fits with a key piece of the Alzheimer's disease puzzle. When the treatment molecule binds to the enzyme, it changes the shape of that puzzle piece so that it no longer fits in its original spot. This halts the chain reaction that leads to the devastating symptoms of Alzheimer's disease."

Ghosh reports his recent work in the May 17 issue of the Journal of Medicinal Chemistry.

Copyright 2007 by United Press International

Explore further: Solid, heat-resistant vaccine to ease immunisation processes

Related Stories

Recommended for you

Solid, heat-resistant vaccine to ease immunisation processes

Apr 30, 2015

EU researchers have set out to substitute liquid and freeze-dried vaccines for new, solid state candidates. If successful, the research will enable the large scale production of new virosome-based vaccines with increased ...

Screening for bacteriuria in pregnant women: Benefit unclear

Apr 30, 2015

Due to a lack of suitable studies, no conclusions can be drawn on the patient-relevant benefit or harm of screening for asymptomatic bacteriuria (ASB) in pregnant women. The benefit of antibiotic treatment of ASB following ...

First generic Abilify approved

Apr 30, 2015

(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.